P3 Health Partners (PIII) Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for P3 Health Partners in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" PIII shares.
View PIII analyst ratings or view top-rated stocks.

2 brokerages have issued 1 year price objectives for P3 Health Partners' stock. Their PIII share price forecasts range from $5.00 to $5.00. On average, they anticipate the company's stock price to reach $5.00 in the next twelve months. This suggests a possible upside of 193.3% from the stock's current price.
View analysts price targets for PIII or view top-rated stocks among Wall Street analysts.

P3 Health Partners' stock was trading at $1.84 on January 1st, 2023. Since then, PIII shares have decreased by 7.3% and is now trading at $1.7050.
View the best growth stocks for 2023 here.

P3 Health Partners saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 4,140,000 shares, an increase of 36.2% from the August 31st total of 3,040,000 shares. Based on an average daily trading volume, of 472,000 shares, the short-interest ratio is currently 8.8 days. Currently, 8.5% of the company's shares are short sold.
View P3 Health Partners' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our PIII earnings forecast.

P3 Health Partners Inc. (NASDAQ:PIII) released its quarterly earnings results on Monday, August, 7th. The company reported ($0.09) earnings per share for the quarter, topping analysts' consensus estimates of ($0.24) by $0.15. The firm earned $329.09 million during the quarter, compared to analyst estimates of $303.30 million. P3 Health Partners had a negative trailing twelve-month return on equity of 2,471.27% and a negative net margin of 10.92%.

P3 Health Partners issued an update on its FY 2023 earnings guidance on Monday, August, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.20 billion-$1.25 billion, compared to the consensus revenue estimate of $1.24 billion.

P3 Health Partners trades on the NASDAQ under the ticker symbol "PIII."

Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PIII stock can currently be purchased for approximately $1.71.

P3 Health Partners (NASDAQ:PIII) has a market capitalization of $533.12 million and generates $1.05 billion in revenue each year. The company earns $-270,130,000.00 in net income (profit) each year or ($2,260.8101) on an earnings per share basis.

The company employs 600 workers across the globe.

P3 Health Partners' mailing address is 2045 W GRAND AVE STUITE B, CHICAGO IL, 60612. The official website for the company is foresightacq.com. The company can be reached via phone at 702-910-3950 or via email at shalper@lifesciadvisors.com.